This company listing is no longer active
TruBridge Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 1/6
TruBridgeDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -42.1% zurückgegangen, während in der Branche Healthcare Services die Gewinne wachsen. Die Umsatzerlöse sind gewachsen mit einer durchschnittlichen Rate von 5.1% pro Jahr. TruBridge Die Eigenkapitalrendite des Unternehmens beträgt 2.5%, und die Nettomargen liegen bei 1.2%.
Wichtige Informationen
-42.11%
Wachstumsrate der Gewinne
-42.16%
EPS-Wachstumsrate
| Healthcare Services Wachstum der Industrie | 1.72% |
| Wachstumsrate der Einnahmen | 5.11% |
| Eigenkapitalrendite | 2.46% |
| Netto-Marge | 1.23% |
| Letzte Ertragsaktualisierung | 31 Mar 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
TBRG: IKS Deal, Legal Probes And Reclassified Outlook Will Shape Re Rating
Analysts have lifted the TruBridge price target from $22.00 to about $25.44, citing updated assumptions around revenue growth, profit margins and a lower P/E multiple. This view is supported by recent research that includes both price target increases and rating downgrades, as well as commentary on the potential IKS acquisition.
TBRG: Pending IKS Buyout Will Likely Expose Execution Risks
The analyst price target for TruBridge has moved from $15 to $23. Analysts attribute this change to adjustments in fair value assumptions, a lower discount rate, and updated expectations for revenue growth, profit margins, and future P/E.TBRG: Potential IKS Deal And EHR Execution Will Shape Future Re Rating
TruBridge's analyst fair value estimate has shifted from $21.00 to $22.00 as analysts update their models around potential IKS-related opportunities, as well as recent mixed price target moves across the Street. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential IKS transaction as aligned with TruBridge's ongoing review of its business.
AI And Global Delivery Expansion Will Reshape Rural Hospital Solutions Over The Next Decade
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and patient care software and services to hospitals, with a focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?TruBridge: Potential Takeover Target, Upside Fundamentally Supported
Summary TruBridge, Inc. is undergoing an operational turnaround with margin expansion, rising EBITDA, and a shift to high-quality recurring revenue. A potential $600 million takeover by Inventurus Knowledge Systems offers a 36–40% premium to current prices but introduces binary deal risk. TBRG’s recurring revenue remains high at 94%, with stable cash flows and improved profitability despite flat top-line growth. The implied takeover valuation aligns with sector multiples, suggesting the upside is fundamentally supported, not purely speculative. Read the full article on Seeking AlphaTBRG: Revenue Cycle Momentum And EHR Stability Will Support Future Re Rating
Analysts have trimmed their price targets on TruBridge, with the average moving from about $22.67 to $21.00 as they weigh a slightly higher discount rate, modestly different revenue growth and margin assumptions, and a lower future P/E multiple against the company's mix of Revenue Cycle Management growth potential and stable Electronic Health Records operations. Analyst Commentary Recent research updates on TruBridge reflect a mix of optimism around the business model and caution around execution and valuation.AI Expansion And Global Delivery Shift Will Shape A Steady But Capped Future
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and electronic health record solutions to hospitals and healthcare providers, with a particular focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Returns At TruBridge (NASDAQ:TBRG) Appear To Be Weighed Down
What are the early trends we should look for to identify a stock that could multiply in value over the long term...TBRG: Revenue Cycle Focus And EHR Stability Will Test Execution Outcomes
Narrative Update The analyst price target for TruBridge has shifted modestly higher to about $22.67 per share, supported by analysts citing the potential of its Revenue Cycle Management focus alongside a steadier Electronic Health Records business, while still calling out execution risk after recent periods of low growth. Analyst Commentary Recent research points to a mixed but constructive view on TruBridge, with analysts focusing on the shift toward Revenue Cycle Management and the steadier Electronic Health Records business when considering valuation and execution risk.TBRG: Revenue Cycle Realignment And EHR Stability Will Require Steady Execution
Narrative Update The analyst price target for TruBridge now centers around US$23, a modest lift from the prior US$22.60. Analysts point to the potential of the Revenue Cycle Management opportunity alongside a steadier Electronic Health Records business, while still flagging execution risk after recent periods of low growth.TBRG: Revenue Cycle Shift Will Demand Proven Execution Before Rerating
Analysts raised their price target on TruBridge modestly, citing improving growth prospects from the company’s shift toward revenue cycle management as evidence builds of its long-term earnings potential. Analyst Commentary Bullish Takeaways Bullish analysts view the company’s realignment toward revenue cycle management as a structurally higher growth opportunity compared with its legacy clinical software offerings.TBRG: Revenue Cycle Pivot Will Require Clear Execution Evidence In 2025
Analysts have nudged their price target on TruBridge slightly higher to approximately $22.60 per share. This reflects increased confidence that the company’s shift toward revenue cycle management can unlock more attractive, evidence-based growth than its legacy clinical software focus.TBRG: Measured Optimism Will Depend On Evidence Of Execution In 2025
TruBridge's analyst price target has been revised downward from $24.75 to $22.60. Analysts cite recent coverage reflecting cautious optimism about the company's strategic shift toward revenue cycle management, while awaiting clearer evidence of execution before turning more positive.Solid Earnings Reflect TruBridge's (NASDAQ:TBRG) Strength As A Business
Even though TruBridge, Inc.'s ( NASDAQ:TBRG ) recent earnings release was robust, the market didn't seem to notice. We...AI And India Hub Will Boost Future Healthcare Efficiency
Despite a notable improvement in TruBridge’s net profit margin and a significant decline in its future P/E ratio, the consensus analyst price target has been sharply revised down from $29.25 to $24.75. What's in the News TruBridge lowered its full-year 2025 revenue guidance to $345 million-$350 million from a previous range of $345 million-$360 million; third quarter 2025 revenue is forecasted at $85 million-$87 million.Digital Automation And AI Will Drive Healthcare Transformation
Increased AI-driven automation, expanded SaaS offerings, and digital transformation are expected to boost operational efficiency, recurring revenue growth, and earnings quality.Would TruBridge (NASDAQ:TBRG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...TruBridge, Inc. (NASDAQ:TBRG) Shares Fly 27% But Investors Aren't Buying For Growth
TruBridge, Inc. ( NASDAQ:TBRG ) shares have continued their recent momentum with a 27% gain in the last month alone...TruBridge, Inc.'s (NASDAQ:TBRG) Business And Shares Still Trailing The Industry
TruBridge, Inc.'s ( NASDAQ:TBRG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right now...Aufschlüsselung der Einnahmen und Ausgaben
Wie TruBridge Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 346 | 4 | 105 | 32 |
| 31 Dec 25 | 347 | 4 | 100 | 33 |
| 30 Sep 25 | 347 | 3 | 101 | 33 |
| 30 Jun 25 | 345 | -11 | 101 | 33 |
| 31 Mar 25 | 345 | -18 | 98 | 33 |
| 31 Dec 24 | 342 | -20 | 96 | 35 |
| 30 Sep 24 | 337 | -59 | 86 | 37 |
| 30 Jun 24 | 335 | -54 | 77 | 39 |
| 31 Mar 24 | 334 | -52 | 84 | 40 |
| 31 Dec 23 | 337 | -47 | 104 | 39 |
| 30 Sep 23 | 337 | -1 | 80 | 36 |
| 30 Jun 23 | 337 | 5 | 88 | 33 |
| 31 Mar 23 | 335 | 11 | 81 | 32 |
| 31 Dec 22 | 327 | 16 | 78 | 32 |
| 30 Sep 22 | 317 | 18 | 77 | 31 |
| 30 Jun 22 | 305 | 19 | 76 | 32 |
| 31 Mar 22 | 290 | 22 | 71 | 30 |
| 31 Dec 21 | 281 | 18 | 70 | 33 |
| 30 Sep 21 | 273 | 16 | 71 | 31 |
| 30 Jun 21 | 272 | 18 | 69 | 32 |
| 31 Mar 21 | 263 | 14 | 70 | 34 |
| 31 Dec 20 | 264 | 14 | 70 | 33 |
| 30 Sep 20 | 268 | 22 | 68 | 34 |
| 30 Jun 20 | 269 | 20 | 68 | 35 |
| 31 Mar 20 | 275 | 20 | 71 | 36 |
| 31 Dec 19 | 275 | 20 | 71 | 37 |
| 30 Sep 19 | 276 | 16 | 75 | 37 |
| 30 Jun 19 | 277 | 18 | 76 | 37 |
| 31 Mar 19 | 279 | 17 | 77 | 37 |
| 31 Dec 18 | 280 | 17 | 78 | 36 |
| 30 Sep 18 | 286 | -11 | 82 | 36 |
| 30 Jun 18 | 284 | -15 | 81 | 35 |
| 31 Mar 18 | 284 | -13 | 81 | 34 |
| 31 Dec 17 | 277 | -17 | 80 | 34 |
| 30 Sep 17 | 263 | 6 | 75 | 34 |
| 30 Jun 17 | 261 | 5 | 75 | 34 |
| 31 Mar 17 | 262 | 6 | 73 | 34 |
| 31 Dec 16 | 267 | 4 | 72 | 29 |
| 30 Sep 16 | 247 | 5 | 63 | 27 |
| 30 Jun 16 | 227 | 7 | 61 | 22 |
| 31 Mar 16 | 206 | 11 | 55 | 18 |
| 31 Dec 15 | 182 | 18 | 52 | 14 |
| 30 Sep 15 | 184 | 21 | 50 | 11 |
Qualität der Erträge: TBRG hat einen großen einmalig Verlust von $10.0M verbucht, der sich auf die Finanzergebnisse der letzten 12 Monate bis zum 31st March, 2026 auswirkt.
Wachsende Gewinnspanne: TBRG in der Vergangenheit profitabel geworden.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: TBRGDie Erträge des Unternehmens sind in den letzten 5 Jahren um 42.1% pro Jahr zurückgegangen.
Beschleunigtes Wachstum: TBRG ist im letzten Jahr profitabel geworden, so dass die Wachstumsrate der Gewinne nur schwer mit dem 5-Jahres-Durchschnitt verglichen werden kann.
Erträge im Vergleich zur Industrie: TBRG ist im letzten Jahr profitabel geworden, so dass es schwierig ist, das Gewinnwachstum des letzten Jahres mit dem der Branche Healthcare Services (12.4%) zu vergleichen.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: TBRGDie Eigenkapitalrendite des Unternehmens (2.5%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/10 16:44 |
| Aktienkurs zum Tagesende | 2026/07/08 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
TruBridge, Inc. wird von 22 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Matthew Gillmor | Baird |
| Stephanie Davis | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |